Related

Healthcare & Medical

Japan has quickly become a world leader in healthcare by several measures, and has enjoyed particular success in increasing Japanese life expectancy. Central to Japan's approach has been the objective of ensuring universal health care, which has been achieved in practice by universal access. Find out more about Japan's healthcare and medical industries below.

About Healthcare & Medical

As expressed by the phrase “from the cradle to the grave”, the Ministry of Health, Labour and Welfare (MHLW) is the ministry that stands closest to the Japanese people.

Hospital Procurement

In a 2011 research survey of Japanese hospitals, three-quarters of surveyed hospitals said they were “dissatisfied” with current practices of purchase and procurement of medicines and medical devices in Japan.  The mean reasons for dissatisfaction given were

Medical & Dental Devices

Since FY2014, the Japanese Government is implementing a 5-year long “Healthcare and Medical Strategy” under the principal philosophy of realizing a society with a long healthy life expectancy as well as economic growth through cutting-edge medical technologies and ser

Pharmaceuticals

It is argued that Japan is “the best market in the world right now” for foreign drug companies.The increasing attractiveness of Japan’s pharmaceutical market is due to recent decisions taken by the Japanese government to liberalise the Japan’s drugs market in several

Quasi drugs

Defined by the Pharmaceutical and Medical Devices Act, a "pharmaceutical product" is a medicine that has been approved for the efficacy of its ingredients and is intended to treat a disease.

Telemedicine and e-Health

With the help of the government, telemedicine and telecare projects are being conducted all over Japan (Hokkaido, Iwate, Kagawa, etc.).

Vitamins & Supplements

In 2012, the size of the Japanese market for nutritional supplements exceeded $7 billion. The single largest selling supplement was vitamin C, and 53 other nutritional supplement products enjoyed sales in excess of $2 billion.